Adaptimmune Therapeutics PLC (ADAP)
0.264
0.00 (0.00%)
USD |
NASDAQ |
Apr 25, 16:00
0.264
0.00 (0.00%)
After-Hours: 20:00
Adaptimmune Therapeutics Shareholders Equity (Quarterly): 11.85M for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Biodexa Pharmaceuticals PLC | 10.44M |
| NuCana PLC | 7.471M |
| Autolus Therapeutics PLC | 427.32M |
| Mereo BioPharma Group PLC | 60.97M |
| TC BioPharm (Holdings) PLC | 2.535M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 245.96M |
| Total Liabilities (Quarterly) | 234.11M |
| Debt to Equity Ratio | 4.240 |
| Current Ratio | 2.916 |
| Net Debt Paydown Yield | -7.29% |